Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GFY | News: GFY Godfreys Group Granted Increase To $30 Mln Senior Debt Facility By Principal Financier | 03/07/18 | 0 | 1.1K | |||
|
|||||||
GFY | Ann: Debt Facility Update | 03/07/18 | 0 | 1.6K | |||
|
|||||||
GFY | Ann: Change in substantial holding | 03/07/18 | 3 | 3.7K | |||
|
|||||||
GFY | Ann: ASX Notice- Suspension and Removal | 29/06/18 | 0 | 1.1K | |||
|
|||||||
GFY | Ann: Compulsory Acquisition Notice | 29/06/18 | 0 | 2.5K | |||
|
|||||||
GFY | Ann: Change in substantial holding | 29/06/18 | 0 | 1.9K | |||
|
|||||||
GFY | Ann: Change in substantial holding | 28/06/18 | 1 | 1.5K | |||
|
|||||||
GFY | Ann: Godfreys begins turnaround campaign | 26/06/18 | 0 | 1.7K | |||
|
See All Discussions